venture capital
Showing all 2 results
-
From Novel Biotechnology Platform to Globally Competitive Cancer Company: Proacta Inc.
8,00 $ – 50,00 $CASE STUDY. This decision-based case focuses on whether Proacta should raise more funds within New Zealand alone, syndicate a venture capital round with international investors, or seek a trade sale of the company.
-
Marcel Choquette et le Fonds d’investissement de la culture et des communications
8,00 $ – 50,00 $ÉTUDE DE CAS. Ce cas relate les premières années du FICC et la contribution de son pdg, Marcel Choquette.
Showing all 2 results